Examkin

Soru

Zorluk: ZorMonitoring and Treatment Evaluation

A 4242-year-old female with a history of bipolar disorder is brought to the emergency department by her family due to progressively worsening lethargy, coarse tremors, and severe ataxia over the past three days. She has been stable on lithium carbonate for five years but was recently prescribed lisinopril for hypertension by her primary care physician. Initial laboratory evaluation reveals a serum lithium concentration of 3.8 mEq/L3.8 \text{ mEq/L} and a serum creatinine of 2.4 mg/dL2.4 \text{ mg/dL} (baseline 0.9 mg/dL0.9 \text{ mg/dL}). Arrange the following therapeutic and monitoring actions in the most appropriate chronological sequence for managing this patient's condition.

  1. 1Administer aggressive intravenous isotonic saline to restore intravascular volume and promote renal lithium clearance.
  2. 2Initiate an emergent session of intermittent hemodialysis to rapidly reduce the intravascular lithium burden.
  3. 3Measure serum lithium concentrations every 22 to 44 hours immediately following the completion of the dialysis session.
  4. 4Perform a second session of hemodialysis to manage the predictable rebound in serum lithium levels caused by tissue redistribution.
  5. 5Transition to daily serum lithium monitoring once levels stabilize below 1.0 mEq/L1.0 \text{ mEq/L} without further extracorporeal removal.

Cevap

The correct clinical sequence is to begin with intravenous fluid resuscitation, proceed to emergent intermittent hemodialysis, monitor lithium levels every 2 to 4 hours to detect tissue rebound, perform a repeat hemodialysis session if rebound reaches toxic levels, and finally transition to daily monitoring once stable.
Severe acute-on-chronic lithium toxicity with acute kidney injury (AKI) requires a specific sequenced treatment and monitoring protocol. Management must begin with aggressive isotonic intravenous fluids to correct volume depletion and maximize glomerular filtration. Because the patient demonstrates severe neurological symptoms and a lithium level >2.5 mEq/L>2.5 \text{ mEq/L} with AKI, emergent intermittent hemodialysis is definitively indicated to rapidly clear the toxin. Crucially, lithium has a large volume of distribution and shifts slowly from the intracellular to the intravascular space. Hemodialysis only clears the intravascular compartment; thus, once dialysis stops, lithium redistributes from tissues back into the blood. Therefore, the treatment evaluation necessitates measuring serum levels every 22 to 44 hours immediately post-dialysis to monitor for this 'rebound' effect. A second hemodialysis session is frequently required to clear this redistributed load. Finally, once levels are consistently <1.0 mEq/L<1.0 \text{ mEq/L} without further rebound, monitoring can be safely de-escalated to a daily frequency.

Adım Adım Çözüm

1
Administer aggressive intravenous isotonic saline.
Corrects hypovolemia and maximizes endogenous renal clearance.
The patient's lithium retention is worsened by ACE inhibitor-induced efferent arteriolar vasodilation and volume depletion. Restoring renal perfusion is the mandatory first step while coordinating advanced therapies.
2
Initiate intermittent hemodialysis.
Rapidly extracts lithium from the intravascular compartment.
Hemodialysis is strictly indicated for lithium toxicity when serum levels exceed 2.5 mEq/L in the setting of acute kidney injury, severe neurological symptoms, or both.
3
Measure serum lithium concentrations every 2 to 4 hours post-dialysis.
Evaluates the expected post-dialysis rebound in serum lithium concentration.
Because lithium slowly moves from the intracellular to the intravascular space, a significant rebound in serum levels predictably occurs 2 to 8 hours after the termination of hemodialysis.
4
Perform a second session of hemodialysis.
Clears the redistributed intravascular lithium burden.
The rebound phenomenon often pushes serum levels back into the toxic range, requiring sequential dialysis runs to achieve definitive clearance.
5
Transition to daily serum lithium monitoring.
Confirms sustained non-toxic levels without extracorporeal assistance.
Once the rebound phase has passed and levels remain consistently sub-therapeutic or normal (<1.0 mEq/L), intensive monitoring can be safely de-escalated.

Anahtar Kavram

Management and post-dialysis rebound monitoring in severe lithium toxicity.
Bu soruyu puanla

Konular

Monitoring and Treatment Evaluation

Bu konudan daha fazla soru